Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.73 HKD | -1.90% | +1.05% | -7.30% |
05-14 | CSPC Pharma's Flu Medication Gets Registration Approval in China | MT |
04-26 | CSPC Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.30% | 10.4B | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- 1093 Stock
- News CSPC Pharmaceutical Group Ltd.
- CSPC Pharmaceutical : Nomura Adjusts CSPC's Price Target to HK$13.7 From HK$12, Keeps at Buy